Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ecopipam Treatment of Tourette Syndrome

NCT01244633 is registered in ClinicalTrials.gov with Psyadon Pharma as lead sponsor.

NCT NCT01244633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01244633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ecopipam Treatment of Tourette Syndrome
Lead sponsor
Psyadon Pharma
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2010
Completion date
July 31, 2013
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tourette's syndrome